Oral nystatin prophylaxis and neonatal fungal infections

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 94, Issue 6, 2009, Pages

  Howell, A ^a,b   Isaacs, D ^a,c   Halliday, R ^a   Barfield, C ^d   Bourchier, D ^e   Bury, G ^f   Dargaville, P ^f   Bucens, I ^g   Ruben, A ^g   Cartwright, D ^h   Clothier, T ⁱ   Ehrlich, J ⁱ   Morey, F ⁱ   Darlow, B ^e   Fraser, S ^j   Gilbert, L ^k   Grimwood, K ^e   Daley, A ^l   McDougall, P ^l   Royle, J ^l   Henderson Smart, D ^m   Jeffery, H ^m   Kohan, R ⁿ   McPhee, A ^o   Messer, R ^p   Minutillo, C ^q   Tudehope, D ^r   Whitehall, J ^s   more..

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SYDNEY   (Australia)

^d MONASH MEDICAL CENTRE   (Australia)

^e Hobart Hospital ^*

^f Hobart Hospital   (Australia)

^g ROYAL DARWIN HOSPITAL   (Australia)

^h ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

ⁱ ALICE SPRINGS HOSPITAL   (Australia)

^j Mercy Health Victoria   (Australia)

^k WESTMEAD HOSPITAL   (Australia)

^l ROYAL CHILDREN'S HOSPITAL   (Australia)

^m ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁿ KING EDWARD MEMORIAL HOSPITAL   (Australia)

^o WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^p CAIRNS BASE HOSPITAL   (Australia)

^q PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^r MATER HOSPITAL   (Australia)

^s Kirwan Hospital   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NYSTATIN; PLACEBO;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUSTRALIA AND NEW ZEALAND; BIRTH WEIGHT; BLOOD CULTURE; CANDIDA; CANDIDA ALBICANS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA PARAPSILOSIS; CEREBROSPINAL FLUID CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FUNGAL MENINGITIS; FUNGEMIA; GESTATIONAL AGE; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INVASIVE CANDIDIASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEWBORN; NEWBORN INFECTION; NEWBORN MORTALITY; NONHUMAN; PRIORITY JOURNAL; VERY LOW BIRTH WEIGHT;

ANTIFUNGAL AGENTS; AUSTRALIA; CANDIDIASIS; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; INTENSIVE CARE, NEONATAL; NEW ZEALAND; NYSTATIN; PROSPECTIVE STUDIES;

EID: 70350468867     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2008.157123     Document Type: Article

References (27)

1. Baley JE, Kliegman RM, Fanaroff AA. Disseminated fungal infections in very low birth-weight infants: clinical manifestations and epidemiology. Pediatrics 1984;73:144-152
2. Weese-Maye DE, Fondriest DW, Brouilette RT, et al. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr Infect Dis J 1987;6:190-196 (Pubitemid 17116140)
3. Faix RG, Kovarik SM, Shaw TR, et al. Mucocutaneous and invasive candidiasis among very low birth weight (<1500 grams) infants in intensive care nurseries: a prospective study. Pediatrics 1989;83:101-107
4. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients: the National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J 2000;19:319-324
5. Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117:84-92. (Pubitemid 46050523)
6. Manzoni P, Farina D, Galletto P, et al. Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J Perinat Med 2007;35:220-226 (Pubitemid 46700985)
7. Clerihew L, Austin N, McGuire W. Systemic antifungal prophylaxis for very-low-birthweight infants: systematic review. Arch Dis Child Fetal Neonatal Ed 2008;93:F198-200. (Pubitemid 352039286)
8. Kaufman D, Boyle R, Hazen KC, et al. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med 2001;345:1660-1666 (Pubitemid 33126821)
9. Kicklighter SD, Springer SC, Cox T, et al. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics 2001;107:293-298 (Pubitemid 32121244)
10. Cabrera C, Frank M, Carter D, et al. Fluconazole prophylaxis against systemic candidiasis after colonization: a randomized, double-blinded study. J Perinatol 2002;22:604.
11. Fridkin SK, Kaufman D, Edwards JR, et al. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Paediatrics 2006;117:1680-1687
12. Clerihew L, Lamagni TL, Brocklehurst P, et al. Invasive fungal infection in very low birthweight infants: national prospective surveillance study. Arch Dis Child Fetal Neonatal Ed 2006;91:F188-92. (Pubitemid 43667617)
13. Clerihew L, McGuire W. Antifungal prophylaxis for very-low-birth-weight infants: UK national survey. Arch Dis Child Fetal Neonatal Ed 2008;93:F238-9. (Pubitemid 352039296)
14. Cabrera C, Frank M, Carter D, et al. Fluconazole prophylaxis against systemic candidiasis after colonization: a randomized, double-blinded study. J Perinatol 2002;22:604.
15. Aghai ZH, Mudduluru M, Nakhla TA, et al. Fluconazole prophylaxis in extremely low birth weight infants: association with cholestasis. J Perinatol 2006;26:550-555 (Pubitemid 44305065)
16. Brion LP, Uko SE, Goldman DL. Risk of resistance associated with flucaonzole prophylaxis: systematic review. J Infect 2007;54:521-529
17. Manzoni P, Leonessa M, Galletto P, et al. Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies. Pediatr Infect Dis J 2008;27:731-737
18. Daley AJ, Isaacs D. Ten-year study in the effect of intra-partum antibiotic prophylaxis on early onset Group B Streptococcal and Escherichia coli neonatal sepsis in Australasia. Pediatr Infect Dis J 2004;23:630-634 (Pubitemid 38924887)
19. AIHW National Perinatal Statistics Unit: http://www.npsu.unsw.edu.au (accessed 26 Jun 2009).
20. Statistics New Zealand: http://www.stats.govt.nz/ (accessed 26 Jun 2009).
21. Benjamin DK, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117:84-92. (Pubitemid 46050523)
22. Manzoni P, Stolfi I, Pugni L, et al. A multicenter, randomized trial of prophylactic fluconazole in preterm neonates. N Engl J Med 2007;356:2483-2495 (Pubitemid 46919774)
23. Isaacs D. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole, or nothing? Curr Opin Infect Dis 2008;21:246-250
24. Sims ME, Yoo Y, You H, et al. Prophylactic oral nystatin and fungal infections in very-low-birthweight infants. Am J Perinatol 1988;5:33-36 (Pubitemid 18046526)
25. Ganesan K, Harigopal S, Neal T, et al. Prophylactic oral nystatin for preterm babies under 33 weeks gestation decreases fungal colonisation and invasive fungaemia. Arch Dis Child Feta Neonatal Ed 2009;94:F275-8.
26. Clerihew L, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 2007;(4):CD003850. (Pubitemid 351805355)
27. Healy CM, Baker CJ. Fluconazole in the neonatal intensive care unit. Pediatr Infect Dis J 2009;28:49-52.